INTERLEUKIN GENETICS ANNOUNCES CONFERENCE CALL TO DISCUSS FIRST QUARTER 2009 RESULTS
05/07/2009
WALTHAM, MA – May 7, 2009 – Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call and webcast on Thursday, May 14, 2009, at 4:30 p.m. EDT to review the Company’s new business developments and first quarter financial results.
To access the live call, dial 877-397-0291 (domestic) or 719-325-4857 (international). The live webcast and replay access of the teleconference will be available on the Investors section of the Company’s Website at http://www.ilgenetics.com.
About Interleukin Genetics
Interleukin Genetics, Inc. (NYSE Amex: ILI), is a genetics-focused personalized health company that develops preventative consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventative and therapeutic products. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit http://www.ilgenetics.com.
# # #
Contacts:
Media:
Erin Walsh
Interleukin Genetics
781-419-4707
ewalsh@ilgenetics.com
Investor Relations:
Melanie Friedman
Stern Investor Relations
212-362-1200
Melanie@sternir.com
  |